{"id":1005837,"date":"2026-09-24T16:53:20","date_gmt":"2026-09-24T20:53:20","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\/"},"modified":"2026-09-24T16:53:20","modified_gmt":"2026-09-24T20:53:20","slug":"mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\/","title":{"rendered":"Mineralys Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum"},"content":{"rendered":"<div class=\"mw_release\">\n<p>RADNOR, Pa., Sept.  24, 2026  (GLOBE NEWSWIRE) &#8212; Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as chronic kidney disease, obstructive sleep apnea and other diseases driven by dysregulated aldosterone, announced today that management will be participating in the Stifel 2026 Virtual Cardiometabolic Forum taking place on September 30, 2026.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"3\">\n            <strong>Stifel 2026 Virtual Cardiometabolic Forum<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:25%;width:25%;min-width:25%\">Date:<\/td>\n<td style=\"max-width:2%;width:2%;min-width:2%\">\u00a0<\/td>\n<td style=\"max-width:73%;width:73%;min-width:73%\">Wednesday, September 30, 2026<\/td>\n<\/tr>\n<tr>\n<td>Time:\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>12:00pm ET<\/td>\n<\/tr>\n<tr>\n<td>Format:\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>Fireside Chat<\/td>\n<\/tr>\n<\/table>\n<p>A live webcast of this fireside chat can be accessed on the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ghEH01mSKbZ79UZmF02l_26P5W1JDVZHlrenzyg9O65H8g4B_HdQDOmMK_E16X-e4H2y-xukE0IVmBYLa1G8nKB-DZ7LdPByqs2uy6GAJubgx6m6JMM1PNYM4VnsvJfR\" rel=\"nofollow\" target=\"_blank\">News &amp; Events<\/a>\u201d page in the Investor Relations section of the Mineralys Therapeutics website.<\/p>\n<p>\n        <strong>About Mineralys Therapeutics<\/strong><br \/>\n        <br \/>Mineralys Therapeutics is a biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease, obstructive sleep apnea and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is an investigational, proprietary, orally administered, highly selective aldosterone synthase inhibitor. Mineralys is based in Radnor, Pennsylvania, and was founded by Catalys Pacific. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XiLotp28rKhnG9nvA8VAn_8aOpNwWI4rudRrzG0Ry1Qw-f3HIfQMkh_bmZhOp0FWMNVMC5prKgCmD747IB66T5e-bBUN2ff0FbLIlQMTYg78vAmeh3Sg-7VMmtI3i6kWwq2sN_QzDOtbMVYVf07l6Stq0LiqH_H47zA11Sc5JDwK-vdxDwXSuVDodSE1bayjQgojuf7rNrjOUhrvfz2HUbbFE0ozSggXav2DFaJvMPqtCpPGvLu2peRUeOJXyJDk4eIxb1hSWopF1vc2lJ6NxU19QdGPkFvobTSUmlltz4Q7nQ4s5sw3zpXA3RhJEQiXeEAp_d1H0X5xzBejnmOn9FU0xuP0s_AfU2ojTuNWo_zN07One6ZPmWVwPF1ta5ukWY4XJejsU8wohPSwjsPZ0vcerFOtmzWBaD-WcRCNmoSoAPgKt_tTfAF-Kq6vUg10hYe6HugXmYkvo5tjI9319XWintFm6MUHDdSWPS3zubR0JTL5OiDqHH29a58hLETH\" rel=\"nofollow\" target=\"_blank\">https:\/\/mineralystx.com<\/a>. Follow Mineralys on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rK95brze2KxMzlVIlylY6Bs71ZeumEnyE9isvMy2S89L19IpaygkUHMgAsljFacDSsYhSHbVy0OKJTzLY95KvGuAos4YeLdVOeGqGcJ9MsfrEUe4x4lXgxmQj4mUo8bdvCgc0GKhY4vRu8qzy6Xjos_W1Qx-2ILZ7OXV94xro8Y7IxKaRDX1jd0OkYSme-1fhQGND48IzXHWRVW-28XFOXPwbw17tCdAfd5uUDulp26IBLshx_JCWwhhnmZRrvtt0lOxy1jTzNIrJ5RjLAXw2REeortHWby89yo4FD5x1zeiOvIX1CyTge9RGDTdI0n4k9k0KZ9cJ550F3_ZariE41InOoYofXqJl_SGasXaYV-lolCv1ZxF1opJBWycvPmOys4jsUJW8LEI9FSpYXJGsY2oiHPqaPvWR9xhQsdvfcxoYmyH2RJlEDeTg0uLtgLpXtxjWOBX5kj79FqOyJzNa4Xn0j5s6F_pPtcC1rgtfrnHL8Hqf0Ot0998jfXyVsc1bkKtY-WThupWaOsdOzygK6QOMBKy3dhfSfRqhtK9iahhwnhdyAz8r5UN3aFj7QDR\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vrtB-aHgwLNIjpzgwjsO2hp_yob12XQ-YtOrdCwF2e_mhjRFjdjV5AvbB94XLIgIk-qVKmmPbdWX5zDlSogRltNmUv4z4DgJlKKBz1oSn6g1PAMv92orvZ7bQh5JeEoZLMiAVcGyg6dLliRen860f9-BzbEP4OxZmgeGtmmkfPZAUwAXQ83COorJKbA46rDUE65ISLZ5PuBBKWWcWsDl6g==\" rel=\"nofollow\" target=\"_blank\">X<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lA6iAQweW5dzhxr7aiKA6Sc5-AdYaV2_YwDBuMwM6AHDtDBsupPUO4tQtEHBORMEttH5VQBubnSpt3Qk_m4hKJGKTDcbCxXw5LoW7qmap1o=\" rel=\"nofollow\" target=\"_blank\">Bluesky<\/a>.<\/p>\n<p>\n        <strong>Contact:<\/strong>\n      <\/p>\n<p>\n        <strong>Investor Relations <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Zm9cHnylyaQuODCQLB-XVOjaQNZ5XWK_ByfZ2CBbpY3xP_V18sepM5Tg4PEEZBAJ-EFMug0j_lyWVuoL4rlq6PfvFfYthRTP2cnB8kroF12MxnYcHfRT6jGuhdMB6qmaELCx_j3pCXVOxxbrZvEmrw==\" rel=\"nofollow\" target=\"_blank\">investorrelations@mineralystx.com<\/a>\n      <\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzMzU5OCM3ODYyNzQwIzUwMDExMzcwMQ==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MGNkNzY2MzctN2E2MC00Yjk0LWFlZDQtMzJiMWI1Y2UzYjZkLTUwMDExMzcwMS0yMDI2LTA5LTI0LWVu\/tiny\/Mineralys-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>RADNOR, Pa., Sept. 24, 2026 (GLOBE NEWSWIRE) &#8212; Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as chronic kidney disease, obstructive sleep apnea and other diseases driven by dysregulated aldosterone, announced today that management will be participating in the Stifel 2026 Virtual Cardiometabolic Forum taking place on September 30, 2026. Stifel 2026 Virtual Cardiometabolic Forum Date: \u00a0 Wednesday, September 30, 2026 Time:\u00a0 \u00a0 12:00pm ET Format:\u00a0 \u00a0 Fireside Chat A live webcast of this fireside chat can be accessed on the \u201cNews &amp; Events\u201d page in the Investor Relations section of the Mineralys Therapeutics website. About Mineralys Therapeutics Mineralys Therapeutics is a biopharmaceutical company focused &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Mineralys Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1005837","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Mineralys Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mineralys Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"RADNOR, Pa., Sept. 24, 2026 (GLOBE NEWSWIRE) &#8212; Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as chronic kidney disease, obstructive sleep apnea and other diseases driven by dysregulated aldosterone, announced today that management will be participating in the Stifel 2026 Virtual Cardiometabolic Forum taking place on September 30, 2026. Stifel 2026 Virtual Cardiometabolic Forum Date: \u00a0 Wednesday, September 30, 2026 Time:\u00a0 \u00a0 12:00pm ET Format:\u00a0 \u00a0 Fireside Chat A live webcast of this fireside chat can be accessed on the \u201cNews &amp; Events\u201d page in the Investor Relations section of the Mineralys Therapeutics website. About Mineralys Therapeutics Mineralys Therapeutics is a biopharmaceutical company focused &hellip; Continue reading &quot;Mineralys Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-24T20:53:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzMzU5OCM3ODYyNzQwIzUwMDExMzcwMQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Mineralys Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum\",\"datePublished\":\"2026-09-24T20:53:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\\\/\"},\"wordCount\":192,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzMzU5OCM3ODYyNzQwIzUwMDExMzcwMQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\\\/\",\"name\":\"Mineralys Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzMzU5OCM3ODYyNzQwIzUwMDExMzcwMQ==\",\"datePublished\":\"2026-09-24T20:53:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzMzU5OCM3ODYyNzQwIzUwMDExMzcwMQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzMzU5OCM3ODYyNzQwIzUwMDExMzcwMQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mineralys Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mineralys Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\/","og_locale":"en_US","og_type":"article","og_title":"Mineralys Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum - Market Newsdesk","og_description":"RADNOR, Pa., Sept. 24, 2026 (GLOBE NEWSWIRE) &#8212; Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as chronic kidney disease, obstructive sleep apnea and other diseases driven by dysregulated aldosterone, announced today that management will be participating in the Stifel 2026 Virtual Cardiometabolic Forum taking place on September 30, 2026. Stifel 2026 Virtual Cardiometabolic Forum Date: \u00a0 Wednesday, September 30, 2026 Time:\u00a0 \u00a0 12:00pm ET Format:\u00a0 \u00a0 Fireside Chat A live webcast of this fireside chat can be accessed on the \u201cNews &amp; Events\u201d page in the Investor Relations section of the Mineralys Therapeutics website. About Mineralys Therapeutics Mineralys Therapeutics is a biopharmaceutical company focused &hellip; Continue reading \"Mineralys Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-24T20:53:20+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzMzU5OCM3ODYyNzQwIzUwMDExMzcwMQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Mineralys Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum","datePublished":"2026-09-24T20:53:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\/"},"wordCount":192,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzMzU5OCM3ODYyNzQwIzUwMDExMzcwMQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\/","name":"Mineralys Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzMzU5OCM3ODYyNzQwIzUwMDExMzcwMQ==","datePublished":"2026-09-24T20:53:20+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzMzU5OCM3ODYyNzQwIzUwMDExMzcwMQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzMzU5OCM3ODYyNzQwIzUwMDExMzcwMQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-forum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Mineralys Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1005837","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1005837"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1005837\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1005837"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1005837"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1005837"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}